Alkermes (ALKS)
(Real Time Quote from BATS)
$24.44 USD
-0.37 (-1.49%)
Updated Jun 14, 2024 11:18 AM ET
3-Hold of 5 3
A Value B Growth D Momentum B VGM
Brokerage Reports
Alkermes plc [ALKS]
Reports for Purchase
Showing records 261 - 280 ( 288 total )
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
PECIALTY PHARMACEUTICALS:Do Your Homework Over the Summer Because the Fall Will Be Explosive with Major PDUFA Activity
Provider: WEDBUSH SECURITIES INC.
Analyst: BANK P
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
Life Sciences: Biopharmaceuticals / Biotechnology.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
Terminating Coverage.
Provider: JESUP & LAMONT SECURITIES
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
AM Comments
Provider: JESUP & LAMONT SECURITIES
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
AM Comments.
Provider: JESUP & LAMONT SECURITIES
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
We are initiating coverage on with a Buy rating and a price target of $15.00.
Provider: JESUP & LAMONT SECURITIES
Analyst: LIN C
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
Company: Alkermes plc
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences : Upcoming Events for the Week of April 25
Provider: WEDBUSH SECURITIES INC.